Abstract
912P Toripalimab in combination with anlotinib in previously treated recurrent or metastatic nasopharyngeal carcinoma: The interim analysis of the single-arm, phase II TORAL study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have